.svg){kind=small}
Jul-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Beard Bros Pharms has shown a noteworthy entry into the Tincture & Sublingual category in California as of July 2025, securing the 21st rank. This is a significant achievement, considering the brand was not in the top 30 in the preceding months of April, May, and June 2025. The absence of rankings in these months indicates that the brand was either not present in the market or not competitive enough to make it to the top 30, making the July ranking a positive development. This upward movement suggests a growing acceptance and potential increase in consumer preference for Beard Bros Pharms' products within this specific category.
While the brand's performance in other states and categories is not detailed here, the available data from California suggests a strategic focus on the Tincture & Sublingual category. The sales figures in July 2025 indicate a tangible presence in the market, despite the lack of prior rankings. This could imply a successful marketing or distribution strategy that has started to bear fruit. Observers might find it interesting to track whether this trend continues in the coming months and whether Beard Bros Pharms will expand its influence in other states or categories.
Competitive Landscape
In the competitive landscape of California's Tincture & Sublingual category, Beard Bros Pharms has faced notable challenges in maintaining its rank among the top brands. As of July 2025, Beard Bros Pharms was ranked 21st, indicating a drop from previous months where it did not appear in the top 20. This suggests a need for strategic adjustments to regain competitive positioning. In contrast, Kind Medicine has shown resilience, maintaining a presence in the top 20 with a rank of 19th in both May and July 2025. Meanwhile, Saida also re-entered the top 20 in July, securing the 20th spot. The fluctuating ranks of these competitors highlight the dynamic nature of the market and underscore the importance for Beard Bros Pharms to innovate and enhance its market strategies to boost sales and improve its ranking.
Notable Products
In July 2025, the High THC Full Spectrum Oil Syringe (1g) from Beard Bros Pharms maintained its top position in the Concentrates category, consistently holding the number one rank for four consecutive months with sales reaching 233 units. The THC:CBD 20:1 HighTHC Spectrum Tincture (600mg THC, 30mg CBD, 30ml, 1oz) climbed back to the second position after a brief dip to fourth in June, showcasing notable recovery with sales doubling from the previous month. The THC/CBN 2:1 Nighttime Tincture (600mg THC, 300mg CBN, 1oz) slipped to third place, despite a steady increase in sales figures since April. The CBD/THC 10:1 High Full Spectrum Oil (1g) ranked fourth, experiencing a decline in sales over the months. Overall, the product rankings in July reflect strategic shifts in consumer preference towards a balanced mix of THC and CBD formulations.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
